WHAT IS NEW
October
1
2021
UPCOMING GCC MEETING:

14th GCC Closed Forum For Bioanalysis

Orlando Disney Springs, FL, USA (Hilton Orlando Lake Buena Vista)

April
15
2021
Most Recent GCC White Paper
October
1
2019
GCC Consolidated Feedback to ICH
PAST GCC PUBLICATIONS:

12th GCC Closed Forum: critical reagents; oligonucleotides; CoA; method transfer; HRMS; flow cytometry; regulatory findings; stability and immunogenicity - This Conference Report was published on Bioanalysis Journal.

WHITE PAPER: Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis - This White Paper was published on Bioanalysis Journal.

11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation - This Conference Report was published on Bioanalysis Journal.

10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraud - This Conference Report was published on Bioanalysis Journal

9th GCC: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooks - This Conference Report was published on Bioanalysis Journal

WHITE PAPER: Recommendations on Incurred Sample Stability (ISS) by GCC - This White Paper was published on Bioanalysis Journal

WHITE PAPER: Recommendations on Biomarker Bioanalytical Validation by GCC - This White Paper was published on Bioanalysis Journal

View More...

CONTACT US:

If you have any questions regarding GCC and GCC activities, please contact Wei Garofolo, the operational coordinator of GCC.